TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Social Support and Education in Asthma Follow-up (SSEA)
Brief Summary: We will evaluate the effect of an eighteen-month asthma coaching intervention for parents/caregivers of children with asthma to reduce asthma morbidity. The primary objective is to determine if asthma coaching will significantly reduce asthma morbidity as measured by a reduction in the number of ED visits and hospitalizations for the children during the 18 months of active coaching and during the 18 months after the coaching stops.

We will provide half of the subjects (parents/caregivers) with access to assistance from an asthma coach for 18 months (including 2 contacts with an asthma nurse during the first 6 months). The other half of the subjects will not have an asthma coach, but their children will have their usual routine care with their primary care providers. The nurse and coach will help the subjects learn more about caring for their children's asthma and improving interactions with the primary care providers for their children.


Options:
A: Arm Label: Coaching group for lifestyle changes; Type: EXPERIMENTAL; Interventions: Behavioral: Coaching | Arm Label: Routine pediatric care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Coaching; Assigned to Arm(s): Coaching group for lifestyle changes
B: Arm Label: CAPS; Type: EXPERIMENTAL; Interventions: Behavioral: Counselor-assisted problem solving (CAPS) | Arm Label: IRC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Internet-resource comparison (IRC) | Intervention Type: BEHAVIORAL; Name: Counselor-assisted problem solving (CAPS); Assigned to Arm(s): CAPS | Intervention Type: BEHAVIORAL; Name: Internet-resource comparison (IRC); Assigned to Arm(s): IRC
C: Arm Label: Social learning and cognitive behavioral therapy (SLCBT); Type: EXPERIMENTAL; Interventions: Behavioral: Social Learning and Cognitive Behavioral Therapy (SLCBT) | Arm Label: Education Support (ES); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education Support (ES) | Intervention Type: BEHAVIORAL; Name: Social Learning and Cognitive Behavioral Therapy (SLCBT); Assigned to Arm(s): Social learning and cognitive behavioral therapy (SLCBT) | Intervention Type: BEHAVIORAL; Name: Education Support (ES); Assigned to Arm(s): Education Support (ES)
D: Arm Label: Teen Online Problem Solving; Type: EXPERIMENTAL; Interventions: Behavioral: Teen Online Problem Solving | Arm Label: Internet Resources Comparison; Type: EXPERIMENTAL; Interventions: Behavioral: Teen Online Problem Solving | Intervention Type: BEHAVIORAL; Name: Teen Online Problem Solving; Assigned to Arm(s): Internet Resources Comparison, Teen Online Problem Solving

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Arm Label: Feedback group; Type: EXPERIMENTAL; Interventions: Behavioral: Feedback of daily walking activity | Arm Label: No-feedback group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Feedback of daily walking activity; Assigned to Arm(s): Feedback group
B: Intervention Type: BEHAVIORAL; Name: Shared-Decision Making; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
D: Arm Label: Conventional rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional rehabilitation. | Arm Label: Novel rehabilitation approach; Type: EXPERIMENTAL; Interventions: Behavioral: Novel rehabilitation approach | Intervention Type: BEHAVIORAL; Name: Conventional rehabilitation.; Assigned to Arm(s): Conventional rehabilitation | Intervention Type: BEHAVIORAL; Name: Novel rehabilitation approach; Assigned to Arm(s): Novel rehabilitation approach

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Arm Label: Integrative Medicine; Type: EXPERIMENTAL; Interventions: Behavioral: Integrative Medicine | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Integrative Medicine; Assigned to Arm(s): Integrative Medicine
B: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Shared-Decision Making; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: Disease Management; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Disease Management + Educational Home Visits; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Arm Label: Patient decision aids; Type: EXPERIMENTAL; Interventions: Other: Patient decision aid | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Patient decision aid; Assigned to Arm(s): Patient decision aids
B: Intervention Type: BEHAVIORAL; Name: Shared-Decision Making; Assigned to Arm(s): N/A
C: Arm Label: usual primary care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PELICAN Primary care; Type: EXPERIMENTAL; Interventions: Other: PELICAN Primary Care | Arm Label: usual secondary care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PELICAN Secondary Care; Type: EXPERIMENTAL; Interventions: Other: PELICAN Secondary Care | Intervention Type: OTHER; Name: PELICAN Primary Care; Assigned to Arm(s): PELICAN Primary care | Intervention Type: OTHER; Name: PELICAN Secondary Care; Assigned to Arm(s): PELICAN Secondary Care
D: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
B: Arm Label: Weekly SMS, brief message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Daily SMS, Brief message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Daily SMS, Long Message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Arm Label: Weekly SMS, Long Message; Type: EXPERIMENTAL; Interventions: Behavioral: Short Message Services to Support ARV therapy adherence | Intervention Type: BEHAVIORAL; Name: Short Message Services to Support ARV therapy adherence; Assigned to Arm(s): Control Group, Daily SMS, Brief message, Daily SMS, Long Message, Weekly SMS, Long Message, Weekly SMS, brief message
C: Arm Label: Arm 1: Collaborative Care Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Care Interventions | Arm Label: Arm 2: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Collaborative Care Interventions; Assigned to Arm(s): Arm 1: Collaborative Care Intervention
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Health Workers Intervention | Arm Label: B; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Health Workers and Mobile Phone Intervention | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer Health Workers Intervention; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Peer Health Workers and Mobile Phone Intervention; Assigned to Arm(s): B

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile phone technology | Intervention Type: BEHAVIORAL; Name: Mobile phone technology; Assigned to Arm(s): 2
B: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
C: Arm Label: Nurse group; Type: EXPERIMENTAL; Interventions: Behavioral: Self management education | Arm Label: Lay educator group; Type: EXPERIMENTAL; Interventions: Behavioral: Self management education | Intervention Type: BEHAVIORAL; Name: Self management education; Assigned to Arm(s): Lay educator group, Nurse group
D: Intervention Type: BEHAVIORAL; Name: Shared-Decision Making; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Intervention Type: PROCEDURE; Name: Written Action Plan for Acute Asthma; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: Shared-Decision Making; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
D: Arm Label: Case Group; Type: N/A; Interventions: N/A | Arm Label: Control Group; Type: N/A; Interventions: Other: MyMediHealth access | Intervention Type: OTHER; Name: MyMediHealth access; Assigned to Arm(s): Control Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Intervention Type: BEHAVIORAL; Name: UNITED Planned Care; Assigned to Arm(s): N/A
B: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Health coaching | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health coaching; Assigned to Arm(s): 1
D: Arm Label: Health coaching; Type: EXPERIMENTAL; Interventions: Behavioral: Health coaching | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care | Intervention Type: BEHAVIORAL; Name: Health coaching; Assigned to Arm(s): Health coaching

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
B: Arm Label: FP/SAL 250/50mcg BID plus GSK2190915 300mg QD (AM); Type: EXPERIMENTAL; Interventions: Drug: FP/SAL 250/50mcg BID, Drug: GSK2190915 200mg QD (AM), Drug: GSK2190915 100mg QD (AM), Drug: Placebo capsule (PM) | Arm Label: FP/SAL 250/50mcg BID plus montelukast 10mg QD (PM); Type: ACTIVE_COMPARATOR; Interventions: Drug: FP/SAL 250/50mcg BID, Drug: Montelukast 10mg QD (PM), Drug: Placebo tablets (2) (AM) | Arm Label: FP/SAL 250/50mcg BID plus placebo BID; Type: PLACEBO_COMPARATOR; Interventions: Drug: FP/SAL 250/50mcg BID, Drug: Placebo tablets (2) (AM), Drug: Placebo capsule (PM) | Intervention Type: DRUG; Name: FP/SAL 250/50mcg BID; Assigned to Arm(s): FP/SAL 250/50mcg BID plus GSK2190915 300mg QD (AM), FP/SAL 250/50mcg BID plus montelukast 10mg QD (PM), FP/SAL 250/50mcg BID plus placebo BID | Intervention Type: DRUG; Name: GSK2190915 200mg QD (AM); Assigned to Arm(s): FP/SAL 250/50mcg BID plus GSK2190915 300mg QD (AM) | Intervention Type: DRUG; Name: GSK2190915 100mg QD (AM); Assigned to Arm(s): FP/SAL 250/50mcg BID plus GSK2190915 300mg QD (AM) | Intervention Type: DRUG; Name: Montelukast 10mg QD (PM); Assigned to Arm(s): FP/SAL 250/50mcg BID plus montelukast 10mg QD (PM) | Intervention Type: DRUG; Name: Placebo tablets (2) (AM); Assigned to Arm(s): FP/SAL 250/50mcg BID plus montelukast 10mg QD (PM), FP/SAL 250/50mcg BID plus placebo BID | Intervention Type: DRUG; Name: Placebo capsule (PM); Assigned to Arm(s): FP/SAL 250/50mcg BID plus GSK2190915 300mg QD (AM), FP/SAL 250/50mcg BID plus placebo BID
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Salmeterol, Montelukast | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Montelukast Placebo | Intervention Type: DRUG; Name: Montelukast Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Salmeterol, Montelukast; Assigned to Arm(s): 1
D: Intervention Type: DRUG; Name: fluticasone propionate/salmeterol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: fluticasone propionate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: montelukast; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To improve asthma outcomes by developing and evaluating strategies for enhancing the clinic-patient partnership. To develop a model of shared decision-making for asthma treatment, and to evaluate it in a two-year randomized clinical trial in 342 adults aged 18-70 years with sub-optimally controlled persistent asthma.


Options:
A: Intervention Type: DRUG; Name: Montelukast; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): N/A
B: Arm Label: Montelukast/Salmeterol; Type: EXPERIMENTAL; Interventions: Drug: Montelukast sodium, Drug: Salmeterol xinafoate, Drug: Fluticasone propionate, Drug: Montelukast matching placebo, Drug: Salmeterol matching placebo | Arm Label: Salmeterol/Montelukast; Type: EXPERIMENTAL; Interventions: Drug: Montelukast sodium, Drug: Salmeterol xinafoate, Drug: Fluticasone propionate, Drug: Montelukast matching placebo, Drug: Salmeterol matching placebo | Intervention Type: DRUG; Name: Montelukast sodium; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast | Intervention Type: DRUG; Name: Salmeterol xinafoate; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast | Intervention Type: DRUG; Name: Fluticasone propionate; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast | Intervention Type: DRUG; Name: Montelukast matching placebo; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast | Intervention Type: DRUG; Name: Salmeterol matching placebo; Assigned to Arm(s): Montelukast/Salmeterol, Salmeterol/Montelukast
C: Intervention Type: BEHAVIORAL; Name: Shared Decision-Making; Assigned to Arm(s): N/A
D: Arm Label: Fluticasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: fluticasone, Drug: montelukast, Drug: Fluticasone plus salmeterol | Arm Label: Montelukast; Type: EXPERIMENTAL; Interventions: Drug: fluticasone, Drug: montelukast, Drug: Fluticasone plus salmeterol | Arm Label: Fluticasone plus salmeterol; Type: EXPERIMENTAL; Interventions: Drug: fluticasone, Drug: montelukast, Drug: Fluticasone plus salmeterol | Intervention Type: DRUG; Name: fluticasone; Assigned to Arm(s): Fluticasone, Fluticasone plus salmeterol, Montelukast | Intervention Type: DRUG; Name: montelukast; Assigned to Arm(s): Fluticasone, Fluticasone plus salmeterol, Montelukast | Intervention Type: DRUG; Name: Fluticasone plus salmeterol; Assigned to Arm(s): Fluticasone, Fluticasone plus salmeterol, Montelukast

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zinc Therapy in Zinc Deficient HIV Positive Drug Users
Brief Summary: Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse drugs and have low plasma zinc levels.


Options:
A: Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: ZINC; Assigned to Arm(s): N/A
C: Arm Label: Zinc gluconate; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: zinc | Intervention Type: DIETARY_SUPPLEMENT; Name: zinc; Assigned to Arm(s): Placebo, Zinc gluconate
D: Arm Label: LNS-Zn5; Type: EXPERIMENTAL; Interventions: Dietary Supplement: LNS-Zn5 | Arm Label: LNS-Zn10; Type: EXPERIMENTAL; Interventions: Dietary Supplement: LNS-Zn10 | Arm Label: LNS-Zn0; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: LNS-Zn0 | Arm Label: Suppl-Zn5; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Suppl-Zn5 | Arm Label: Delayed intervention group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: LNS-Zn5; Assigned to Arm(s): LNS-Zn5 | Intervention Type: DIETARY_SUPPLEMENT; Name: LNS-Zn10; Assigned to Arm(s): LNS-Zn10 | Intervention Type: DIETARY_SUPPLEMENT; Name: LNS-Zn0; Assigned to Arm(s): LNS-Zn0 | Intervention Type: DIETARY_SUPPLEMENT; Name: Suppl-Zn5; Assigned to Arm(s): Suppl-Zn5

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zinc Therapy in Zinc Deficient HIV Positive Drug Users
Brief Summary: Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse drugs and have low plasma zinc levels.


Options:
A: Arm Label: 4000IU; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cholecalciferol (Vit D3) | Arm Label: 7000IU; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cholecalciferol (Vit D3) | Intervention Type: DRUG; Name: Cholecalciferol (Vit D3); Assigned to Arm(s): 4000IU, 7000IU
B: Arm Label: Multivitamins (B,C,E); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multivitamin supplements B,C and E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Multivitamin supplements B,C and E | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamin supplements B,C and E; Assigned to Arm(s): Multivitamins (B,C,E), Placebo
C: Arm Label: Zinc gluconate; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: zinc | Intervention Type: DIETARY_SUPPLEMENT; Name: zinc; Assigned to Arm(s): Placebo, Zinc gluconate
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Vitamin D 4000 IU; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): Vitamin D 4000 IU | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Soft Drink, Milk and Obesity in Chilean Children
Brief Summary: The primary aim of this randomized controlled trial is to evaluate the effects of replacing habitual consumption of sugar-sweetened soft drinks with milk over 16 weeks.


Options:
A: Intervention Type: BEHAVIORAL; Name: Weekly home delivery of milk products; Assigned to Arm(s): N/A
B: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Policy and Environmental Change; Type: EXPERIMENTAL; Interventions: Behavioral: Policy and Environmental Change | Intervention Type: BEHAVIORAL; Name: Policy and Environmental Change; Assigned to Arm(s): Policy and Environmental Change
C: Arm Label: Targeted beverage education and financial incentives; Type: EXPERIMENTAL; Interventions: Behavioral: Targeted beverage education and financial incentives, Behavioral: Traffic-light labeling of all beverages in store | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Behavioral: Traffic-light labeling of all beverages in store | Intervention Type: BEHAVIORAL; Name: Targeted beverage education and financial incentives; Assigned to Arm(s): Targeted beverage education and financial incentives | Intervention Type: BEHAVIORAL; Name: Traffic-light labeling of all beverages in store; Assigned to Arm(s): Control, Targeted beverage education and financial incentives
D: Arm Label: Low intensity arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary, physical activity and sleeping | Arm Label: High intensity arm; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary, physical activity and sleeping | Intervention Type: BEHAVIORAL; Name: Dietary, physical activity and sleeping; Assigned to Arm(s): High intensity arm, Low intensity arm

Answer: A